Profil
Andrew Anzalone is the founder of Prime Medicine, Inc. and holds the title of Head-Prime Editing Platform since 2019.
Education includes an undergraduate degree from Brown University and a doctorate from The Trustees of Columbia University in The City of New York.
Aktive Positionen von Andrew Anzalone
| Unternehmen | Position | Beginn |
|---|---|---|
| PRIME MEDICINE, INC. | Gründer | 13.09.2019 |
Ausbildung von Andrew Anzalone
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prime Medicine, Inc.
Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
















